C
XERS icon

Cliffwater’s Xeris Biopharma Holdings XERS Stock Holding History

Cliffwater’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.08M Buy
+263,158
New +$1.68M 0.52% 14

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Cliffwater's XERS Position: Q2 2026 in Review

Cliffwater opened a new position in Xeris Biopharma Holdings (XERS) in Q2 2026: 263,158 shares worth $2.08M. The stake represents 0.52% of the portfolio and ranks #14 among its holdings.

239 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Cliffwater held 263,158 shares of Xeris Biopharma Holdings worth $2.08M as of Q2 2026.
  • Xeris Biopharma Holdings was a new Cliffwater position in Q2 2026.
  • Xeris Biopharma Holdings made up 0.52% of Cliffwater's portfolio in Q2 2026, its #14 holding.
  • 239 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Cliffwater's 13F filing for Q2 2026, filed 12 Aug 2026.